Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0641
D

Failure to Accurately Document Parkinson's Disease in MDS Assessment

Duarte, California Survey Completed on 05-15-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that the Minimum Data Set (MDS) assessment accurately reflected a resident's active diagnosis of Parkinson's disease. Despite documentation in the resident's admission record, physician orders, and neurology consultation notes indicating a diagnosis of Parkinson's disease and ongoing treatment with Sinemet, the MDS did not include Parkinson's disease under the active diagnoses section. The resident was observed to have symptoms consistent with Parkinson's, such as noticeable tremors, and was able to verbally confirm the diagnosis. A review of medication administration records further confirmed that the resident was receiving Sinemet for Parkinson's disease, with periods of discontinuation and restart as ordered by the neurologist. During interviews, the LVN responsible for the MDS assessment was unable to explain why Parkinson's disease was omitted from the MDS and acknowledged the inaccuracy. The neurologist who evaluated the resident noted that follow-up was not conducted by the facility after initiating a Levodopa trial, despite instructions to monitor for adverse reactions. The facility's policy requires that MDS assessments consistently reflect information from progress notes, care plans, and resident observations, which was not followed in this case, resulting in an inaccurate assessment entry for the resident.

An unhandled error has occurred. Reload 🗙